Moreover, Kaplan-Meier analysis of TCGA survival data indicated that elevated expression of USP32 and PD-L1 correlates with worse survival in colon cancer patients (Figure 5O), indicating that high USP32 expression may be associated with an adverse prognosis in colon cancers. Here, CD274 is linked to malignant colon neoplasm.